Cathepsin K gene disruption does not affect murine aneurysm formation

Atherosclerosis

Volumn 209, Issue 1, 2010, Pages 96-103

  Bai, Lili ^a   Beckers, Linda ^a   Wijnands, Erwin ^a   Lutgens, Suzanne P M ^a   Herías, M Verónica ^a   Saftig, Paul ^b   Daemen, Mat J A P ^a   Cleutjens, Kitty ^a   Lutgens, Esther ^a   Biessen, Erik A L ^a,c   Heeneman, Sylvia ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF KIEL   (Germany)

^c LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Aneurysm; Angiotensin II; Cathepsin K; Collagenolytic activity; Elastolytic capacity

Indexed keywords

ANGIOTENSIN II; APOLIPOPROTEIN E; CATHEPSIN K; CATHEPSIN S; COLLAGEN; DIPEPTIDYL PEPTIDASE I; ELASTIN;

ABDOMINAL AORTA; ADVENTITIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ANEURYSM; ARTICLE; CARDIOVASCULAR DISEASE; COLLAGEN DEGRADATION; CONTROLLED STUDY; ELASTOLYSIS; GENE DISRUPTION; GENE EXPRESSION REGULATION; GRANULOCYTE; LEUKOCYTE COUNT; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DEFICIENCY; PROTEIN DEGRADATION; T LYMPHOCYTE; UPREGULATION;

ANGIOTENSIN II; ANIMALS; AORTIC ANEURYSM, ABDOMINAL; APOLIPOPROTEINS E; CATHEPSIN C; CATHEPSIN K; CATHEPSINS; COLLAGEN; GRANULOCYTES; LYMPHOCYTE COUNT; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; T-LYMPHOCYTES;

EID: 77049084492     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.09.001     Document Type: Article

References (28)

1. Daugherty A., and Cassis L.A. Mouse models of abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 24 (2004) 429-434
2. Harthun N.L., Cheanvechai V., Graham L.M., Freischlag J.A., and Gahtan V. Prevalence of abdominal aortic aneurysm and repair outcomes on the basis of patient sex: should the timing of intervention be the same?. J Thorac Cardiovasc Surg 127 (2004) 325-328
3. Isselbacher E.M. Thoracic and abdominal aortic aneurysms. Circulation 111 (2005) 816-828
4. Halloran B.G., and Baxter B.T. Pathogenesis of aneurysms. Semin Vasc Surg 8 (1995) 85-92
5. Thompson R.W., and Parks W.C. Role of matrix metalloproteinases in abdominal aortic aneurysms. Ann NY Acad Sci 800 (1996) 157-174
6. Kadoglou N.P., and Liapis C.D. Matrix metalloproteinases: contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysms. CMRO 20 (2004) 419-432
7. Manning M.W., Cassis L.A., and Daugherty A. Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 23 (2003) 483-488
8. Thompson R.W., Geraghty P.J., and Lee J.K. Abdominal aortic aneurysms: basic mechanisms and clinical implications. Curr Probl Surg 39 (2002) 110-230
9. Garnero P., Borel O., Byrjalsen I., et al. The collagenolytic activity of cathepsin K is unique among mammalian proteinases. J Biol Chem 273 (1998) 32347-32352
10. Gelb B.D., Moissoglu K., Zhang J., et al. Cathepsin K: isolation and characterization of the murine cDNA and genomic sequence, the homologue of the human pycnodysostosis gene. Biochem Mol Med 59 (1996) 200-206
11. Chapman H.A., Riese R.J., and Shi G.P. Emerging roles for cysteine proteases in human biology. Annu Rev Physiol 59 (1997) 63-88
12. Bromme D., and Okamoto K. Human cathepsin O2, a novel cysteine protease highly expressed in osteoclastomas and ovary molecular cloning, sequencing and tissue distribution. Biol Chem Hoppe Seyler 376 (1995) 379-384
13. Liu J., Sukhova G.K., Yang J.T., et al. Cathepsin L expression and regulation in human abdominal aortic aneurysm, atherosclerosis, and vascular cells. Atherosclerosis 184 (2006) 302-311
14. Shi G.P., Sukhova G.K., Grubb A., et al. Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Invest 104 (1999) 1191-1197
15. Abdul-Hussien H., Soekhoe R.G., Weber E., et al. Collagen degradation in the abdominal aneurysm: a conspiracy of matrix metalloproteinase and cysteine collagenases. Am J Pathol 170 (2007) 809-817
16. Lutgens E., Lutgens S.P., Faber B.C., et al. Disruption of the cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation. Circulation 113 (2006) 98-107
17. Saftig P., Hunziker E., Wehmeyer O., et al. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc Natl Acad Sci USA 95 (1998) 13453-13458
18. Daugherty A., Manning M.W., and Cassis L.A. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 105 (2000) 1605-1612
19. Daugherty A., Manning M.W., and Cassis L.A. Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis. Br J Pharmacol 134 (2001) 865-870
20. Wang Y.X., Martin-McNulty B., da Cunha V., et al. Fasudil, a Rho-kinase inhibitor, attenuates angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice by inhibiting apoptosis and proteolysis. Circulation 111 (2005) 2219-2226
21. Donners M.M., Beckers L., Lievens D., et al. The CD40-TRAF6 axis is the key regulator of the CD40/CD40L system in neointima formation and arterial remodeling. Blood 111 (2008) 4596-4604
22. Shimizu K., Mitchell R.N., and Libby P. Inflammation and cellular immune responses in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 26 (2006) 987-994
23. Punturieri A., Filippov S., Allen E., et al. Regulation of elastinolytic cysteine proteinase activity in normal and cathepsin K-deficient human macrophages. J Exp Med 192 (2000) 789-799
24. Lutgens S.P., Kisters N., Lutgens E., et al. Gene profiling of cathepsin K deficiency in atherogenesis: profibrotic but lipogenic. J Pathol 210 (2006) 334-343
25. Treska V., Kocova J., Boudova L., et al. Inflammation in the wall of abdominal aortic aneurysm and its role in the symptomatology of aneurysm. Cytokines Cell Mol Ther 7 (2002) 91-97
26. Satta J., Laurila A., Paakko P., et al. Chronic inflammation and elastin degradation in abdominal aortic aneurysm disease: an immunohistochemical and electron microscopic study. Eur J Vasc Endovasc Surg 15 (1998) 313-319
27. Eliason J.L., Hannawa K.K., Ailawadi G., et al. Neutrophil depletion inhibits experimental abdominal aortic aneurysm formation. Circulation 112 (2005) 232-240
28. Platsoucas C.D., Lu S., Nwaneshiudu I., et al. Abdominal aortic aneurysm is a specific antigen-driven T cell disease. Ann NY Acad Sci 1085 (2006) 224-235